Global DNA Repair Drugs Market 2026 -
Players, Regions, Product Types, Application & Forecast Analysis
Global DNA Repair Drugs Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis
Chapter 1 DNA Repair Drugs Market Overview
1.1 DNA Repair Drugs Definition
1.2 Global DNA Repair Drugs Market Size Status and Outlook (2019-2032)
1.3 Global DNA Repair Drugs Market Size Comparison by Region (2019-2032)
1.4 Global DNA Repair Drugs Market Size Comparison by Type (2019-2032)
1.5 Global DNA Repair Drugs Market Size Comparison by Application (2019-2032)
1.6 Global DNA Repair Drugs Market Size Comparison by Sales Channel (2019-2032)
1.7 DNA Repair Drugs Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts
1.7.6 US-Israel-Iran War Impacts
Chapter 2 Executive Summary
2.1 Global DNA Repair Drugs Market Snapshot
2.2 Global DNA Repair Drugs Market Volume & Revenue (2019-2025)
2.3 Global DNA Repair Drugs Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)
2.4 Global DNA Repair Drugs Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)
2.5 Global DNA Repair Drugs Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)
2.6 Global DNA Repair Drugs Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)
Chapter 3 DNA Repair Drugs Market Segment Analysis by Player
3.1 Global DNA Repair Drugs Sales and Market Share by Player (2023-2025)
3.2 Global DNA Repair Drugs Revenue and Market Share by Player (2023-2025)
3.3 Global DNA Repair Drugs Average Price by Player (2023-2025)
3.4 Players Competition Situation & Trends (2023-2025)
3.5 Conclusion of Segment by Player
Chapter 4 DNA Repair Drugs Market Segment Analysis by Type
4.1 Global DNA Repair Drugs Market by Type
4.1.1 PARP Inhibitors
4.1.2 Others
4.2 Global DNA Repair Drugs Sales and Market Share by Type (2019-2025)
4.3 Global DNA Repair Drugs Revenue and Market Share by Type (2019-2025)
4.4 Global DNA Repair Drugs Average Price by Type (2019-2025)
4.5 Leading Players of DNA Repair Drugs by Type in 2025
4.6 Conclusion of Segment by Type
Chapter 5 DNA Repair Drugs Market Segment Analysis by Application
5.1 Global DNA Repair Drugs Market by Application
5.1.1 Oncological
5.1.2 Stroke
5.2 Global DNA Repair Drugs Revenue and Market Share by Application (2019-2025)
5.3 Leading Consumers of DNA Repair Drugs by Application in 2025
5.4 Conclusion of Segment by Application
Chapter 6 DNA Repair Drugs Market Segment Analysis by Sales Channel
6.1 Global DNA Repair Drugs Market by Sales Channel
6.1.1 Global DNA Repair Drugs Market, by Direct Channel Market Analysis (2019-2032) (USD Million)
6.1.2 Global DNA Repair Drugs Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)
6.2 Global DNA Repair Drugs Revenue and Market Share by Sales Channel (2019-2025)
6.3 Leading Distributors/Dealers of DNA Repair Drugs by Sales Channel in 2025
6.4 Conclusion of Segment by Sales Channel
Chapter 7 DNA Repair Drugs Market Segment Analysis by Region
7.1 Global DNA Repair Drugs Market Size and CAGR by Region (2019-2032)
7.2 Global DNA Repair Drugs Sales and Market Share by Region (2019-2025)
7.3 Global DNA Repair Drugs Revenue and Market Share by Region (2019-2025)
7.4 North America
7.4.1 North America Market by Country
7.4.2 North America DNA Repair Drugs Market Share by Type
7.4.3 North America DNA Repair Drugs Market Share by Application
7.4.4 United States
7.4.5 Canada
7.4.6 Mexico
7.5 Europe
7.5.1 Europe Market by Country
7.5.2 Europe DNA Repair Drugs Market Share by Type
7.5.3 Europe DNA Repair Drugs Market Share by Application
7.5.4 Germany
7.5.5 United Kingdom
7.5.6 France
7.5.7 Italy
7.5.8 Russia
7.5.9 Spain
7.5.10 Benelux
7.5.11 Poland
7.5.12 Austria
7.5.13 Portugal
7.5.14 Rest of Europe
7.6 Asia-Pacific
7.6.1 Asia-Pacific Market by Country
7.6.2 Asia-Pacific DNA Repair Drugs Market Share by Type
7.6.3 Asia-Pacific DNA Repair Drugs Market Share by Application
7.6.4 China
7.6.5 Japan
7.6.6 Korea
7.6.7 India
7.6.8 Southeast Asia
7.6.9 Australia
7.6.10 Taiwan
7.6.11 Rest of Asia Pacific
7.7 South America
7.7.1 South America Market by Country
7.7.2 South America DNA Repair Drugs Market Share by Type
7.7.3 South America DNA Repair Drugs Market Share by Application
7.7.4 Brazil
7.7.5 Argentina
7.7.6 Colombia
7.7.7 Chile
7.7.8 Peru
7.7.9 Venezuela
7.7.10 Rest of South America
7.8 Middle East & Africa
7.8.1 Middle East & Africa Market by Country
7.8.2 Middle East & Africa DNA Repair Drugs Market Share by Type
7.8.3 Middle East & Africa DNA Repair Drugs Market Share by Application
7.8.4 UAE
7.8.5 Saudi Arabia
7.8.6 South Africa
7.8.7 Egypt
7.8.8 Nigeria
7.9.9 Rest of Middle East & Africa
7.9 Conclusion of Segment by Region
Chapter 8 Profile of Leading DNA Repair Drugs Players
8.1 4SC AG
8.1.1 Company Snapshot
8.1.2 Product/Service Offered
8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.1.4 Recent Developments
8.2 ARCAGY/ GINECO GROUP
8.2.1 Company Snapshot
8.2.2 Product/Service Offered
8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.2.4 Recent Developments
8.3 Bristol Myers Squibb
8.3.1 Company Snapshot
8.3.2 Product/Service Offered
8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.3.4 Recent Developments
8.4 British Columbia Cancer Agency
8.4.1 Company Snapshot
8.4.2 Product/Service Offered
8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.4.4 Recent Developments
8.5 Cambridge University Hospitals NHS Foundation Trust
8.5.1 Company Snapshot
8.5.2 Product/Service Offered
8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.5.4 Recent Developments
8.6 Genentech
8.6.1 Company Snapshot
8.6.2 Product/Service Offered
8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.6.4 Recent Developments
8.7 Georgetown University
8.7.1 Company Snapshot
8.7.2 Product/Service Offered
8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.7.4 Recent Developments
8.8 German Breast Group
8.8.1 Company Snapshot
8.8.2 Product/Service Offered
8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.8.4 Recent Developments
8.9 GlaxoSmithKline
8.9.1 Company Snapshot
8.9.2 Product/Service Offered
8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.9.4 Recent Developments
8.10 Jiangsu Hengrui Medicine
8.10.1 Company Snapshot
8.10.2 Product/Service Offered
8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.10.4 Recent Developments
8.11 Johnson & Johnson
8.11.1 Company Snapshot
8.11.2 Product/Service Offered
8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.11.4 Recent Developments
8.12 Jonsson Comprehensive Cancer Center
8.12.1 Company Snapshot
8.12.2 Product/Service Offered
8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.12.4 Recent Developments
8.13 Karyopharm Therapeutics
8.13.1 Company Snapshot
8.13.2 Product/Service Offered
8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.13.4 Recent Developments
8.14 KuDOS Pharmaceuticals
8.14.1 Company Snapshot
8.14.2 Product/Service Offered
8.14.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.14.4 Recent Developments
8.15 National Health Service
8.15.1 Company Snapshot
8.15.2 Product/Service Offered
8.15.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.15.4 Recent Developments
8.16 National Institutes of Health
8.16.1 Company Snapshot
8.16.2 Product/Service Offered
8.16.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.16.4 Recent Developments
8.17 Tesaro
8.17.1 Company Snapshot
8.17.2 Product/Service Offered
8.17.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.17.4 Recent Developments
8.18 Others
8.18.1 Company Snapshot
8.18.2 Product/Service Offered
8.18.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
8.18.4 Recent Developments
Chapter 9 Upstream and Downstream Analysis of DNA Repair Drugs
9.1 Industrial Chain of DNA Repair Drugs
9.2 Upstream of DNA Repair Drugs
9.2.1 Raw Materials (If Applicable)
9.2.2 Manufacturing Cost Structure (If Applicable)
9.2.3 Manufacturing Process (If Applicable)
9.3 Downstream of DNA Repair Drugs
9.3.1 Leading Distributors/Dealers of DNA Repair Drugs
9.3.2 Leading Consumers of DNA Repair Drugs
Chapter 10. Global DNA Repair Drugs Market Industry Analysis
10.1. Porter's Five Forces Analysis
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Buyers/Consumers
10.1.3. Bargaining Power of Suppliers
10.1.4. Threat of Substitute Types
10.1.5. Intensity of Competitive Rivalry
10.2. Major Growth Avenues within Global DNA Repair Drugs Market
10.2.1. Product Types
10.2.2. Applications
10.2.3. Sales Channels
10.2.4. Country
10.3. DNA Repair Drugs Industry Ecosystem
10.4. Price Trend Analysis (If Applicable)
10.5. Buying Criteria (If Applicable)
10.6. Regulations (If Applicable)
Chapter 11 Development Trend of DNA Repair Drugs (2026-2032)
11.1 Global DNA Repair Drugs Market Size (Sales and Revenue) Forecast (2026-2032)
11.2 Global DNA Repair Drugs Market Size and CAGR Forecast by Region (2026-2032)
11.3 Global DNA Repair Drugs Market Size and CAGR Forecast by Type (2026-2032)
11.4 Global DNA Repair Drugs Market Size and CAGR Forecast by Application (2026-2032)
11.5 Global DNA Repair Drugs Market Size and CAGR Forecast by Sales Channel (2026-2032)
Chapter 12. Import - Export Analysis (If Applicable)
12.1 North America DNA Repair Drugs Import-Export (2019-2025)
12.2 Europe DNA Repair Drugs Import-Export (2019-2025)
12.3 Asia Pacific DNA Repair Drugs Import-Export (2019-2025)
12.4 South America DNA Repair Drugs Import-Export (2019-2025)
12.5 Middle East & Africa DNA Repair Drugs Import-Export (2019-2025)
Chapter 13. Demand-Supply Gap Analysis
13.1 North America DNA Repair Drugs Demand-Supply (2019-2025)
13.2 Europe DNA Repair Drugs Demand-Supply (2019-2025)
13.3 Asia Pacific DNA Repair Drugs Demand-Supply (2019-2025)
13.4 South America DNA Repair Drugs Demand-Supply (2019-2025)
13.5 Middle East & Africa DNA Repair Drugs Demand-Supply (2019-2025)
Chapter 14 Appendix
14.1 Research Methodology
14.2 Data Sources
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.